Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remains to be seen. The sidelines have been good to me so far
out on the bounce up
Margin calls everywhere...time to be a vulture
The big dump could have been a margin call or someone looking for a v shape recovery in some blue chips? Could have been anything really. Ha!
Cash into q3 for nbrv. Raise soon?
Been adding last week also
Whew. This is either very ugly or a great buy
69 cents. tempting, but holding off on everything for a while yet.
fun in the ole' pinks
Inovio got called out today and the fallout whacked IPIX
Well, I guess it was really more of a pump after all. Got at least 3 emails making the same basic announcement.
Tau Shows Promise as Achilles’ Heel for Alzheimer’s and Similar Diseases
The protein, once seen as a secondary player, has taken a leading role in combating neurodegenerative illnesses
https://www.scientificamerican.com/article/tau-shows-promise-as-achilles-heel-for-alzheimers-and-similar-diseases/?utm_source=newsletter&utm_medium=email&utm_campaign=today-in-science&utm_content=link&utm_term=2020-03-02_top-stories&spMailingID=64186591&spUserID=MjY0Njk5MDgzNDgS1&spJobID=1840279105&spReportId=MTg0MDI3OTEwNQS2
Well I spoke too soon. This last PR is nothing but a pump (IMO)
I think handing over some B for testing was a good idea. Some apparently interpreted that as a decent probability B will cure COVID-19, and it doubled the price.
Classic pop and drop. Not really a pump and dump, as Leo could have pumped it much more....I'm happy he did not.
pop and drop?
odds are good that IPIX will get no related funding...but it is still worth a try.
B would not be a vaccine of course. Interesting that the cytosorbent blood filter should be an effective therapeutic. Who knows? Maybe B can help.
This anti-viral push (or pump) may actually make sense. The panic level could get high enough that DARPA or some equivalent funding source throws some $ at Brilacidin.
Yeah it’s not shorts. I sold on the pre-market pop and will re enter later. Some whales I know think this is high potential.
Related item....Berkshire-Hathaway and Biogen.
https://www.fiercepharma.com/pharma/a-192m-moat-buffett-s-berkshire-builds-stake-biogen-ahead-key-alzheimer-s-drug-filing
What is the outlook for Promis as far as getting a partner to advace into trials?
positive sign for both BIIB and ARFXF
I thought you meant company losses. My mistake.
IPIX is a one person shop without cash or even a working phone. not a valid comparison in my book
results mean nothing much I guess. oh well, I'll take 8 cents.
It will need to be watched closely because I’m guessing there are a fair number of shares waiting to flip, plus the MFO may have a bunch to sell into the float.
OR take 40%?
sticky
waiting patiently for the flip....coming later this week?
Likely to accelerate...
I would not be surprised by a 20-25% bounce short-term. That's about 12 cents. This was a buck sixty a couple days ago. Not sure the offering and PTSD suspension warrants 53 cents.
Its easy to beat NNVC when they just stand still and make claims.
So why is another loss of 40% or so expected, particularly on top of the 67% haircut just the last couple of days? A cash infusion makes completion of the trials more likely...and imo the PTSD trial was not likely to succeed anyway.
Does this company have anything?
Fast track do all this???
Thanks. I guess now is as good a time as any for liftoff, but it doesn't really feel like anything has changed from a couple weeks ago.
What is driving the sharp increase?
some will use this pop as an exit
Company still needs some sort of financial savior. Odds of getting one have increased with the BT designation.
BRIEF-Resverlogix Receives US FDA Breakthrough Therapy Designation For Apabetalone
But it doesn’t really matter what the analyst say. What matters is whether there’s a company willing to put up the money that will be required to do another phase 3
As far as I can tell so far it’s pretty much of a yawn